Case Report of a Fatal Intoxication by Nucynta

被引:16
作者
Franco, Dori M. [1 ]
Ali, Zabiullah [2 ]
Levine, Barry [2 ]
Middleberg, Robert A. [3 ]
Fowler, David R. [2 ]
机构
[1] Off Armed Forces Med Examiner, Rockville, MD USA
[2] State Maryland, Off Chief Med Examiner, Baltimore, MD USA
[3] NMS Labs, Willow Grove, PA USA
关键词
tapentadol; Nucynta; overdose; postmortem; DOUBLE-BLIND; TAPENTADOL; TRAMADOL; EFFICACY; HCL;
D O I
10.1097/PAF.0b013e3182887804
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Tapentadol (Nucynta) is a centrally acting opioid analgesic prescribed for the treatment of moderate to severe acute pain. Its efficacy is believed to be due to K-opioid receptor agonist activity and inhibition of norepinephrine reuptake resulting in increased norepinephrine concentrations. There is only one other case in the literature relating to the toxicity of this agent or report of a fatality. This case report documents a case in which tapentadol was identified as the cause of death. The tapentadol concentration found in the heart blood submitted in this case was more than 20 times the upper limit of the therapeutic range. Possible mechanisms of death include respiratory depression, central nervous system depression, and serotonin syndrome. Based on the scene investigation and autopsy findings in this case, the medical examiner determined that the cause of death was narcotic (Nucynta) intoxication and the manner of death was undetermined.
引用
收藏
页码:234 / 236
页数:3
相关论文
共 9 条
[1]  
[Anonymous], 2009, J ANAESTH CLIN PHARM
[2]  
Baselt RC, 2004, DISPOSITION TOXIC DR, P1573
[3]   Efficacy and Tolerability of Tapentadol Immediate Release and Oxycodone HCl Immediate Release in Patients Awaiting Primary Joint Replacement Surgery for End-Stage Joint Disease: A 10-Day, Phase III, Randomized, Double-Blind, Active- and Placebo-Controlled Study [J].
Hartrick, Craig ;
Van Hove, Ilse ;
Stegmann, Jens-Ulrich ;
Oh, Charles ;
Upmalis, David .
CLINICAL THERAPEUTICS, 2009, 31 (02) :260-271
[4]   Death Due to Apparent Intravenous Injection of Tapentadol [J].
Kemp, Walter ;
Schlueter, Scott ;
Smalley, Elizabeth .
JOURNAL OF FORENSIC SCIENCES, 2013, 58 (01) :288-291
[5]   Single Dose Analgesic Efficacy of Tapentadol in Postsurgical Dental Pain: The Results of a Randomized, Double-Blind, Placebo-Controlled Study [J].
Kleinert, Regina ;
Lange, Claudia ;
Steup, Achim ;
Black, Peter ;
Goldberg, Jutta ;
Desjardins, Paul .
ANESTHESIA AND ANALGESIA, 2008, 107 (06) :2048-2055
[6]   Deaths involving contraindicated and inappropriate combinations of serotonergic drugs [J].
Pilgrim, Jennifer L. ;
Gerostamoulos, Dimitri ;
Drummer, Olaf H. .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2011, 125 (06) :803-815
[7]   Lethal combination of tramadol and multiple drugs affecting serotonin [J].
Ripple, MG ;
Pestaner, JP ;
Levine, BS ;
Smialek, JE .
AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2000, 21 (04) :370-374
[8]   Fatal unintentional intoxications with tramadol during 1995-2005 [J].
Tjaderborn, Micaela ;
Jonsson, Anna K. ;
Hagg, Staffan ;
Ahlner, Johan .
FORENSIC SCIENCE INTERNATIONAL, 2007, 173 (2-3) :107-111
[9]   (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl):: a novel μ-opioid receptor agonist norepinephrine Reuptake inhibitor with broad-spectrum analgesic properties [J].
Tzschentke, Thomas M. ;
Christoph, Thomas ;
Koegel, Babette ;
Schiene, Klaus ;
Hennies, Hagen-Heinrich ;
Englberger, Werner ;
Haurand, Michael ;
Jahnel, Ulrich ;
Cremers, Thomas I. F. H. ;
Friderichs, Elmar ;
De Vry, Jean .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01) :265-276